These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7980265)

  • 41. Mesenteric venous thrombosis and antithrombin III deficiency.
    Wilson C; Walker ID; Davidson JF; Imrie CW
    J Clin Pathol; 1987 Aug; 40(8):906-8. PubMed ID: 3654990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Premature arterial disease associated with familial antithrombin III deficiency.
    Johnson EJ; Prentice CR; Parapia LA
    Thromb Haemost; 1990 Feb; 63(1):13-5. PubMed ID: 2339350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A cases of antithrombin III (ATIII) deficiency associated with extrahepatic portal occlusion undergoing operation for esophgogastric varices].
    Soeda K; Kozu T; Onoda S; Isono K
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):437-41. PubMed ID: 1603050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hereditary antithrombin III deficiency in an English family.
    Scully MF; De Haas H; Chan P; Kakkar VV
    Br J Haematol; 1981 Feb; 47(2):235-40. PubMed ID: 7470393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Catabolism and distribution of functionally heterogeneous human antithrombin III.
    Marciniak E; Romond EH
    J Lab Clin Med; 1987 Jan; 109(1):89-96. PubMed ID: 3794520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.
    Schulman S; Tengborn L
    Thromb Haemost; 1992 Dec; 68(6):634-6. PubMed ID: 1287876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombin III deficiency as congenital risk factor for venous thrombosis and embolism.
    Strikwerda S; van der Velden L; Swart K; Geerdink R
    Haematologica; 1986; 71(5):407-10. PubMed ID: 3096837
    [No Abstract]   [Full Text] [Related]  

  • 48. Antithrombin-α for the prophylaxis of venous thrombosis in congenital antithrombin deficiency.
    Fyfe A; Tait RC
    Expert Rev Hematol; 2009 Oct; 2(5):499-507. PubMed ID: 21083015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical implications of antithrombin III deficiency.
    Karl R; Garlick I; Zarins C; Cheng E; Chediak J
    Surgery; 1981 Apr; 89(4):429-33. PubMed ID: 7209791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal antithrombin III deficiency.
    Manco-Johnson MJ
    Am J Med; 1989 Sep; 87(3B):49S-52S. PubMed ID: 2679071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
    Lourenço DM; Noguti MA; Juliano L
    Rev Assoc Med Bras (1992); 1995; 41(6):373-8. PubMed ID: 8733245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombin III deficiency and cerebrovascular accidents in young adults.
    Graham JA; Daly HM; Carson PJ
    J Clin Pathol; 1992 Oct; 45(10):921-2. PubMed ID: 1430264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
    Nelson DM; Stempel LE; Brandt JT
    Obstet Gynecol; 1985 Jun; 65(6):848-53. PubMed ID: 4039808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S.
    De Stefano V; Leone G; Mastrangelo S; Tripodi A; Rodeghiero F; Castaman G; Barbui T; Finazzi G; Bizzi B; Mannucci PM
    Thromb Haemost; 1994 Sep; 72(3):352-8. PubMed ID: 7855783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease.
    Harper PL; Luddington RJ; Daly M; Bruce D; Williamson D; Edgar PF; Perry DJ; Carrell RW
    Br J Haematol; 1991 Mar; 77(3):360-4. PubMed ID: 2012760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pregnancy and thrombophilia in women with congenital deficit of antithrombin III, protein C, protein S or plasminogen: analysis of 39 cases].
    Montagud M; Montserrat I; Oliver A; Adelantado JM; Mateo J; Borrell M; Fontcuberta J
    Med Clin (Barc); 1993 Feb; 100(6):201-4. PubMed ID: 8429723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Lu Z; Wang F; Liang M
    Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mesenteric vein infarction associated with congenital antithrombin III (ATIII) deficiency].
    Guillou YM; Bleichner JP; Gobron F; Leroux A; Le Calvé JL; Mallédant Y
    Ann Chir; 1996; 50(1):72-5. PubMed ID: 8734279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombin III deficiency appearing as mesenteric vein thrombosis.
    Pokorney BH; Eyster ME; Jeffries GH
    Am J Gastroenterol; 1981 Dec; 76(6):534-7. PubMed ID: 7331986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.